Most shorted Danish healthcare stocks
Pharmaceuticals, biotech, medical devices and health services. 12 classified Denmark companies, ranked by disclosed short positions as of 31 Jul 2026. Sector average 3.70%.
Cite this page
Plain
Wikipedia
BibTeX
Sector trend
The median disclosed position across the sector's classified companies at each reporting date. A median, not a total: percentages of different companies' capital cannot be added, so this tracks the typical member, with the table below showing today's spread.
| # | Company | Short % | 20d (pp) |
|---|---|---|---|
| 1 | GN Store Nord A/S | 10.25% | −1.01 |
| 2 | Zealand Pharma A/S | 9.29% | +0.07 |
| 3 | Ambu A/S | 7.16% | −0.45 |
| 4 | Demant A/S | 5.39% | −0.31 |
| 5 | ChemoMetec A/S | 3.24% | −0.18 |
| 6 | Bavarian Nordic A/S | 3.04% | +0.70 |
| 7 | Coloplast A/S | 3.03% | +0.25 |
| 8 | Gubra A/S | 1.18% | −0.39 |
| 9 | H. Lundbeck A/S | 0.82% | +0.10 |
| 10 | Genmab A/S | 0.62% | +0.13 |
| 11 | ALK-Abelló A/S | 0.20% | +0.10 |
| 12 | Novo Nordisk A/S | 0.20% | 0.00 |
Reading this table
Sector buckets are our own coarse editorial classification, not the licensed GICS or ICB schemes; only classified companies appear here. The change column is percentage points over 20 trading days. Figures are official Danish FSA disclosures, see the methodology.